Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries ARS Pharmaceuticals, Inc. - Common Stock (NQ: SPRY ) 13.71 +0.51 (+3.86%) Streaming Delayed Price Updated: 2:33 PM EDT, Aug 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about ARS Pharmaceuticals, Inc. - Common Stock < Previous 1 2 3 Next > INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm October 26, 2023 Via ACCESSWIRE NASDAQ:SPRY Investor Notice: Investigation over Potential Securities Laws Violations by ARS Pharmaceuticals, Inc. October 11, 2023 San Diego, CA -- (SBWIRE) -- 10/11/2023 -- ARS Pharmaceuticals, Inc. is under investigation on over potential securities laws violations in connection with certain financial statements. Via SBWire ARS Pharmaceuticals Announces Scheduling of a Type A Meeting with the U.S. FDA for neffy® (epinephrine nasal spray) October 06, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire Single and Repeat Dose Clinical Study of neffy (epinephrine nasal spray) Published in the Journal of Allergy and Clinical Immunology October 03, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire Analyst Expectations for ARS Pharmaceuticals's Future June 21, 2023 Via Benzinga Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session September 26, 2023 Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi... Via Benzinga Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday September 26, 2023 U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities More Than $8M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying September 26, 2023 The Dow Jones closed higher by more than 40 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities ARS Pharmaceuticals' EpiPen Alternative Delayed US Approval - Two Analysts Offer Differing Views September 21, 2023 On Tuesday, The FDA issued a Complete Response Letter regarding ARS Pharmaceuticals Inc's (NASDAQ: SPRY) New Drug Application (NDA) for neffy (epinephrine nasal spray) in the treatment of Allergic... Via Benzinga Exposures Product Safety What's Going On With ARS Pharmaceuticals Stock Today? September 21, 2023 ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) shares are trading higher Thursday. The move marks a rebound in the stock following a recent drop in price. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session September 21, 2023 Via Benzinga Gold Moves Higher; Fed Leaves Key Overnight Interest Rate Unchanged September 20, 2023 U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 200 points on Wednesday. The Dow traded up 0.59% to 34,720.69 while the NASDAQ fell 0.07% to 13,668.37. The S&P 500... Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Why Gorilla Technology Group Shares Are Trading Lower By 25%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session September 20, 2023 Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session September 20, 2023 Via Benzinga Why Shares of ARS Pharmaceuticals Are Plummeting on Wednesday September 20, 2023 The company received a Complete Response Letter from the FDA regarding its lead therapy. Via The Motley Fool Exposures Product Safety Nasdaq Turns Lower; Cambridge Bancorp Shares Surge September 20, 2023 U.S. stocks traded mixed midway through trading, with the Nasdaq Composite turning lower on Wednesday. The Dow traded up 0.56% to 34,711.50 while the NASDAQ fell 0.17% to 13,654.54. The S&P 500 also... Via Benzinga Topics Stocks Exposures US Equities Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2023 September 20, 2023 Via Benzinga Dow Gains 150 Points; General Mills Posts Upbeat Earnings September 20, 2023 U.S. stocks traded higher this morning, with the Dow Jones gaining more than 150 points on Tuesday. The Dow traded up 0.47% to 34,680.84 while the NASDAQ rose 0.26% to 13,713.13. The S&P 500 also rose,... Via Benzinga Topics Stocks Exposures US Equities Elon Musk-Backed Neuralink Starts Participant Enrollment For Paralysis, Eli Lilly Cracks Down on Counterfeit Weight Loss Drugs, Meta Looks to Capitalize on India's In-App Payment Surge: Today's Top Stories September 20, 2023 Benzinga Via Benzinga FDA Rejects EpiPen Alternative - ARS Pharmaceuticals' Allergic Reaction Nasal Spray September 20, 2023 The FDA issued a Complete Response Letter regarding ARS Pharmaceuticals Inc's (NASDAQ: SPRY) New Drug Application (NDA) for neffy (epinephrine nasal spray) in the treatment of Allergic Reactions (Type... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Wednesday's Pre-Market Session September 20, 2023 Via Benzinga Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket September 20, 2023 Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 70.2% to $0.8937 in pre-market trading after falling 10% on Tuesday. Via Benzinga Instacart, ARS Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session September 20, 2023 U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga FDA Issues Complete Response Letter for neffy® (epinephrine nasal spray) New Drug Application with Request for Additional Study September 19, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire ARS Reports Second Quarter 2023 Financial Results and Provides Business Updates August 10, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire ARS Pharmaceuticals Announces PDUFA Date Extension for neffy® (Intranasal (IN) Epinephrine) for the Treatment of Allergic Reactions (Type 1), Including Anaphylaxis June 20, 2023 Additional Time Needed for Labeling and Post-Marketing Requirements Discussions; PDUFA Date Set for September 19, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire ARS Pharmaceuticals Highlights Progress and Reports First Quarter 2023 Financial Results May 15, 2023 From ARS Pharmaceuticals, Inc. Via GlobeNewswire ONEOK, PacWest Bancorp And Other Big Stocks Moving Lower In Monday's Pre-Market Session May 15, 2023 U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session. Via Benzinga Nasdaq Down 100 Points; Crude Oil Drops Over 1% May 12, 2023 U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 100 points on Friday. The Dow traded down 0.43% to 33,164.71 while the NASDAQ fell 0.82% to 12,227.60. The... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session May 12, 2023 Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.